The Association between the Differential Expression of lncRNA and Type 2 Diabetes Mellitus in People with Hypertriglyceridemia
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054279 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shoumeng Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, RNA, Long Noncoding, Insulin-Secreting Cells, Hypertriglyceridemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Graduate Innovative Research Program of Jilin University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Compared with diabetic patients with normal blood lipid, diabetic patients with dyslipidemia such as high triglycerides have a higher risk of clinical complications, and the disease is also more serious. For the subjects with hypertriglyceridemia, the lncRNAs affecting type 2 diabetes mellitus (T2DM) and the specific mechanisms remain unclear. Transcriptome sequencing was performed on peripheral blood samples of new-onset T2DM (six subjects) and normal blood control (six subjects) in hypertriglyceridemia patients using gene chip technology, and differentially expressed lncRNA profiles were constructed. Validated by the GEO database and RT-qPCR, lncRNA ENST00000462455.1 was selected. Subsequently, fluorescence in situ hybridization (FISH), real-time quantitative polymerase chain reaction (RT-qPCR), CCK-8 assay, flow cytometry, and enzyme-linked immunosorbent assay (ELISA) were used to observe the effect of ENST00000462455.1 on MIN6. When silencing the ENST00000462455.1 for MIN6 in high glucose and high fat, the relative cell survival rate and insulin secretion decreased, the apoptosis rate increased, and the expression of the transcription factors Ins1, Pdx-1, Glut2, FoxO1, and ETS1 that maintained the function and activity of pancreatic β cells decreased (p < 0.05). In addition, we found that ENST00000462455.1/miR-204-3p/CACNA1C could be the core regulatory axis by using bioinformatics methods. Therefore, ENST00000462455.1 was a potential biomarker for hypertriglyceridemia patients with T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
- School of Nursing, Jilin University, Changchun 130021, China.
- Department of Nutrition and Food Hygiene, School of Public Health, Jilin University, Changchun 130021, China.
ORCID-Profile: Weiwei Cui, Bo Li
Förderung
- National Natural Science Foundation of China
- Graduate Innovative Research Program of Jilin University
Zitieren
APA
Yan, S., Yao, N., Li, X., Sun, M., Yang, Y., Cui, W., & Li, B. (2023). The Association between the Differential Expression of lncRNA and Type 2 Diabetes Mellitus in People with Hypertriglyceridemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054279
Vancouver
Yan S, Yao N, Li X, Sun M, Yang Y, Cui W, et al. The Association between the Differential Expression of lncRNA and Type 2 Diabetes Mellitus in People with Hypertriglyceridemia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054279
BibTeX
@article{Yan2023,
author = {Yan, Shoumeng and Yao, Nan and Li, Xiaotong and Sun, Mengzi and Yang, Yixue and Cui, Weiwei and Li, Bo},
title = {The Association between the Differential Expression of lncRNA and Type 2 Diabetes Mellitus in People with Hypertriglyceridemia},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054279}
}
EUVIMED